GenePath Diagnostics is a next generation molecular genetics company that provides state-of-the-art clinical in vitro diagnostic services for developing markets and is developing novel next generation diagnostic tests and platforms for the global market. We are an innovation-centric company with a strong emphasis on continuous R&D. We are constantly evolving in pace with global developments in the field and have the ability to develop new tests where needed, e.g. to respond to an emerging pathogen or a rare genetic disorder. We pride ourselves on our ability to work with clinicians to come up with novel or custom solutions to diagnostic problems. At GenePath, we strongly believe in our culture. Our company’s values are the principles and ideals that we live by.